State Street’s Reviva Pharmaceuticals RVPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.3K | Hold |
126,700
| – | – | ﹤0.01% | 4106 |
|
|
2025
Q1 | $121K | Buy |
126,700
+27,300
| +27% | +$26K | ﹤0.01% | 3930 |
|
|
2024
Q4 | $180K | Buy |
99,400
+28,000
| +39% | +$50.7K | ﹤0.01% | 3876 |
|
|
2024
Q3 | $103K | Hold |
71,400
| – | – | ﹤0.01% | 3973 |
|
|
2024
Q2 | $91.4K | Buy |
71,400
+8,200
| +13% | +$10.5K | ﹤0.01% | 4032 |
|
|
2024
Q1 | $239K | Sell |
63,200
-2,300
| -4% | -$8.69K | ﹤0.01% | 3832 |
|
|
2023
Q4 | $337K | Buy |
65,500
+21,100
| +48% | +$109K | ﹤0.01% | 3745 |
|
|
2023
Q3 | $217K | Hold |
44,400
| – | – | ﹤0.01% | 3918 |
|
|
2023
Q2 | $260K | Hold |
44,400
| – | – | ﹤0.01% | 3922 |
|
|
2023
Q1 | $186K | Hold |
44,400
| – | – | ﹤0.01% | 4102 |
|
|
2022
Q4 | $189K | Buy |
+44,400
| New | +$189K | ﹤0.01% | 4125 |
|